drugset / Trial / NCT07094880
Subcuteous Methotrexate in Rheumatoid Arthritis
RandomizedParallel-groupOpen-labelTreatment
Summary
Methotrexate use is important for the treatment of Rheumatoid arthritis. Some patients can not tolerate oral methotrexate. So subcutaneous may help to overcome it.
Timeline
- Start
- 2015-06-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | 25 mg | Oral |